Oncology Firm Erasca Eyes US$300 Million IPO

Precision oncology company Erasca Inc. (NASDAQ: ERAS) began trading on the Nasdaq Global Select Market today under the symbol “ERAS”. The firm’s initial public offering is looking to raise US$300.0 million and is expected to close on July 20, 2021.

The offering will be conducted through the issuance of 18,750,000 common shares selling at US$16.00 per share.

The company granted a 30-day over-allotment option to purchase additional 2,812,500 common shares at the same IPO price, potentially bringing proceeds up to US$345.0 million. J.P. Morgan, Morgan Stanley, BofA Securities, Evercore ISI, and Guggenheim Securities are all acting as joint bookrunners for the said offering.

According to its profile, Erasca is a clinical-stage precision oncology company focused on therapy solutions for RAS/MAPK pathway-driven cancers. The company got its name from its mission statement to “erase cancer”.


Information for this briefing was found via Sedar and Erasca. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

LNG Firm Excelerate Energy Launches IPO

Liquefied natural gas company Excelerate Energy is looking to go public on the New York...

Tuesday, April 5, 2022, 02:21:00 PM

Dating App Grindr Swipes Right To Potential US$2.1 Billion SPAC Merger

LGBTQ+ dating app Grindr announced on Monday the potential business combination agreement with special purpose...

Tuesday, May 10, 2022, 02:25:00 PM

Winery Co-founded By Actresses Nina Dobrev, Julianne Hough Fresh Vine Prices US$22 Million IPO

Napa Valley winery Fresh Vine Wine, Inc. (NYSE: VINE) began trading on the New York...

Tuesday, December 14, 2021, 02:16:00 PM

Birkenstock Files For $8 Billion IPO

Birkenstock, the renowned German footwear company, took a significant step towards going public on Tuesday....

Wednesday, September 13, 2023, 10:36:00 AM

Financial SPAC HCM Acquisition Prices US$250 Million IPO

Special purpose acquisition company HCM Acquisition Corp (Nasdaq: HCMAU) started trading publicly on the Nasdaq...

Friday, January 21, 2022, 02:29:00 PM